Document Detail

Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks.
MedLine Citation:
PMID:  16041629     Owner:  NLM     Status:  MEDLINE    
When compared to the use of 12 hourly 200 microg vaginal misoprostol on its own, the addition of a single dose of 5 mg did not significantly increase the abortion or delivery rate in pregnancy termination at 13-29 weeks gestation. All patients were given intravenous syntocinon at 30 mU/min from the first dose of misoprostol onwards.
Samir Hidar; Mohamed Bouddebous; Anouar Cha?eb; Mehdi Jerbi; Mohamed Bibi; H?di Kha?ri
Related Documents :
10521749 - Selective termination for structural, chromosomal, and mendelian anomalies: internation...
15142599 - Orientated binding of photosynthetic reaction centers on gold using ni-nta self-assembl...
990229 - Termination of abnormal intrauterine pregnancies with intramuscular administration of d...
3370199 - Early pregnancy termination: a comparison between vacuum aspiration and medical abortio...
22115959 - The progesterone receptor regulates implantation, decidualization, and glandular develo...
16788959 - Sonographic appearance of the uterine cavity following administration of mifepristone a...
20860419 - The relationship of preconception thyrotropin levels to requirements for increasing the...
9797109 - Apoptotic cell death in human granulosa-lutein cells: a possible indicator of in vitro ...
428219 - Randomized comparison of clinical performance of two copper-releasing iuds, nova-t and ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2005-07-24
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  273     ISSN:  0932-0067     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-12-05     Completed Date:  2006-08-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  157-60     Citation Subset:  IM    
Department of Obstetrics and Gynaecology, Farhat Hached University Teaching Hospital, 4002, Sousse, Tunisia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortifacient Agents, Nonsteroidal / administration & dosage*
Abortion, Induced*
Administration, Intravaginal
Isosorbide Dinitrate / administration & dosage*
Misoprostol / administration & dosage*
Nitric Oxide Donors / administration & dosage*
Pregnancy Trimester, Second
Prospective Studies
Treatment Outcome
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Nitric Oxide Donors; 59122-46-2/Misoprostol; 87-33-2/Isosorbide Dinitrate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  JNK/ERK-AP-1/Runx2 induction "paves the way" to cartilage load-ignited chondroblastic differentiatio...
Next Document:  Abnormal basement membrane in the inner ear and the kidney of the Mpv17-/- mouse strain: ultrastruct...